$450.00
Value $54.3B
HumanavsEli Lilly and Company
HUM and LLY stock compared: price, dividend, valuation and results, from SEC filings.
+1.42%
$1,443.50
Value $1.36T
Humana (HUM) has a market value of $54.3B and Eli Lilly and Company (LLY) $1.36T. Over the last year, with dividends, HUM moved +89.6% and LLY +42.9%. The P/E is 43.6 for HUM and 49.4 for LLY. Dividend yield: HUM 0.79%, LLY 0.44%.
At a glance
The main figures of both. A bar only shows which number is larger, not which is better.
Market value
HUM$54.3B
LLY$1.36T
LLY is 25 times HUM
Revenue, 12 months
HUM$154B
LLY$86.5B
HUM is 1.8 times LLY
Net income, 12 months
HUM$1.2B
LLY$27.6B
LLY is 22 times HUM
Operating margin
HUM1.5%
LLY–
ROIC
HUM5.7%
LLY35.5%
29.8 points apart
P/E
HUM43.6
LLY49.4
LLY is 1.1 times HUM
Dividend yield
HUM0.8%
LLY0.4%
0.4 points apart
5-year return
HUM+6.2%
LLY+480.4%
474.2 points apart
A fainter bar means a negative number. The 5-year return includes dividends.
The price over time
Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.
HUM+6.2%
LLY+480.5%
| Period | HUMWith dividends | LLYWith dividends |
|---|---|---|
| 1 year since November 12, 2025 | +89.6%Price +87.1% | +42.9%Price +41.8% |
| 3 years since November 13, 2023 | -6.1%-2.1% a yearPrice -9.5% | +140.8%+34.0% a yearPrice +135.6% |
| 5 years since November 12, 2021 | +6.2%+1.2% a yearPrice +1.0% | +480.4%+42.2% a yearPrice +455.9% |
| 10 years since November 15, 2016 | +146.4%+9.4% a yearPrice +126.3% | +2,071.6%+36.0% a yearPrice +1,766.9% |
Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.
Every figure
As on each company's page. A description, not a recommendation: no one figure says which is better.
HUMHumanaLLYEli Lilly and Company
Valuation
HUMLLY| Price | $450.00 | $1,443.50 |
|---|---|---|
| Market value | $54.3B | $1.36T |
| Enterprise value (EV) | $41.7B | $1.41T |
| P/E | 43.6 | 49.4 |
| P/E, 5-year median | 23.2 | 49.9 |
| P/B | 2.9 | 33.8 |
| EV/EBIT | 17.5 | 40.5 |
| Free cash flow yield | 5.8% | 1.4% |
Results and growth
HUMLLY| Revenue, 12 months | $154B | $86.5B |
|---|---|---|
| Net income, 12 months | $1.2B | $27.6B |
| Free cash flow, 12 months | $3.1B | $19.7B |
| Earnings per share, 12 months | $10.30 | $30.81 |
| Revenue growth, year on year | 10.1% | 44.7% |
| Revenue growth a year, past | +10.9%over 5 years | +21.6%over 5 years |
| EPS growth a year, past | -17.2%over 5 years | +27.6%over 5 years |
Margins and returns on capital
HUMLLY| Gross margin | – | 83.6% |
|---|---|---|
| Operating margin | 1.5% | – |
| Net margin | 0.8% | 31.9% |
| ROIC | 5.7% | 35.5% |
| ROE | 6.7% | 88.6% |
Balance sheet
HUMLLY| Cash | $25.1B | $4.9B |
|---|---|---|
| Total debt | $12.5B | $49.5B |
| Net debt / EBITDA | -4.1 | 1.2 |
| Interest cover | 3.2× | 38.9× |
Dividends and buybacks
HUMLLY| Dividend yield | 0.8% | 0.4% |
|---|---|---|
| Dividend per share, 12 months | $3.54 | $6.34 |
| Dividend growth a year, past | +7.8%over 5 years | +15.2%over 5 years |
| Buyback yield | 0.3% | 0.3% |
| Shareholder yield | 1.1% | 0.7% |
Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.
Which is bigger, Humana or Eli Lilly and Company?
By market value, Eli Lilly and Company ($1.36T) is about 25.1 times Humana ($54.3B), at today's prices.
How did HUM and LLY stock do over the last 10 years?
Since November 15, 2016, HUM's price moved +126.3% and LLY's +1,766.9%. With dividends: HUM +146.4% (+9.4% a year), LLY +2,071.6% (+36.0% a year). Past returns do not predict future ones.
Which pays the higher dividend, HUM or LLY?
The dividend yield at today's price is 0.79% for Humana and 0.44% for Eli Lilly and Company. Over the last twelve months they paid $3.54 and $6.34 per share.
What is the P/E of HUM and LLY?
At today's price, the P/E is 43.6 for HUM and 49.4 for LLY. The median of the last five years was 23.2 and 49.9, which shows where each stands against its own past.
Which has the higher profit margins, Humana or Eli Lilly and Company?
Over the last twelve months, the net margin was 0.8% for Humana and 31.9% for Eli Lilly and Company, and the operating margin 1.5% and –. Revenue was $154B and $86.5B.
Which is the better investment, Humana or Eli Lilly and Company?
The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.
Other comparisons
With each of the two, and with the largest in its sector.
Related pages
The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.
US stocksThe market today, the sectors, the largest companies and the week's results.The market's sectorsThe 11 sectors side by side: returns, share of the market, median P/E and dividend.Compare stocksTwo companies side by side: price over up to ten years, with and without dividends, and every figure.US dividend stocksEach dividend's yield next to whether the company's cash covers it and whether it was ever cut.
Descriptive data from SEC filings and market prices.